Investment
Features
FeesSafety
Academy
More
Pluang+

FDA approves Sarclisa Escena, first anticancer drug via on-body injector for multiple myeloma

Company Fundamentals
10 Jul 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

The FDA has approved Sarclisa Escena, a subcutaneous formulation of the multiple myeloma drug Sarclisa, administered via the innovative CirCLIQ on-body injector (OBI). This is the first anticancer treatment approved for delivery through an on-body injector, offering patients a shorter, more convenient treatment with fewer infusion reactions compared to intravenous infusions. Clinical trials showed Sarclisa Escena via OBI matches the efficacy and safety of the IV version while reducing treatment time and physical strain on healthcare providers. This approval could improve patient experience and streamline care for multiple myeloma patients in the US.

More News (SNY)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App